RAIN ENHANCEMENT TECHNO-CL A(NASDAQ:RAIN) stock News

RAIN Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Benzinga - Mentions: HTCO CREG GLBS SGBX ...

12 Industrials Stocks Moving In Tuesday's After-Market Session

2 months ago - By: Benzinga - Mentions: OESX NCL NCRA UAVS ...

12 Industrials Stocks Moving In Wednesday's Intraday Session

6 months ago - By: Rain Enhancement Technologies Holdco, Inc.

Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer

2 years ago - By: Pathos AI, Inc.

Pathos AI Completes Acquisition of Rain Oncology

2 years ago - By: Kahn Swick & Foti, LLC

RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN

2 years ago - By: Brodsky & Smith LLC - Mentions: ABBV AZN CERE CNSL ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.

2 years ago - By: Brodsky & Smith LLC - Mentions: ICVX CNSL CERE AZN ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.

2 years ago - By: Kahn Swick & Foti, LLC

RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN

2 years ago - By: Brodsky & Smith LLC - Mentions: AYX CNSL CERE

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos

2 years ago - By: Halper Sadeh LLC

RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders

2 years ago - By: Seeking Alpha

Rain Oncology to be acquired by Pathos AI for $1.16 in cash per share (NASDAQ:RAIN)

2 years ago - By: Rain Oncology Inc.

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

2 years ago - By: Rain Oncology Inc.

Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

2 years ago - By: Rain Oncology Inc.

Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

2 years ago - By: Seeking Alpha

Rain Oncology gets $1.25/share takeover offer from Tang Capital (NASDAQ:RAIN)

2 years ago - By: Rosen Law Firm, P.A.

ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN

2 years ago - By: The Law Offices of Frank R. Cruz

RAIN ENHANCEMENT TECHNO-CL A (RAIN) Stock News

RAIN Latest News, Press Relases and Analysis

12 Industrials Stocks Moving In Tuesday's After-Market Session

12 Industrials Stocks Moving In Wednesday's Intraday Session

Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer

Pathos AI Completes Acquisition of Rain Oncology

RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.

RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.

Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos

RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders

Rain Oncology to be acquired by Pathos AI for $1.16 in cash per share (NASDAQ:RAIN)

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

Rain Oncology gets $1.25/share takeover offer from Tang Capital (NASDAQ:RAIN)

ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)